After adjustment for time-dependent age and dialysis vintage, gender, diabetes, TAWG, and serum albumin, patients with hyponatremia based on TASNa had a higher risk of new MACE (HR 2.33; 95% CI 1.16–4.68; model 3) compared to those with normonatremia. This evidence concerns the gene ALB and Hyponatremia.